Sophisticated and simple
Overview of Q3 2025 Results Compugen has released its third quarter 2025 results, alongside key data updates from the company’s oncology pipeline. The highlights focus…

Overview: New Data Spotlight Regenerative Macrophage Therapy Resolution Therapeutics has announced key updates from its ongoing research into Regenerative Macrophage Therapy (RMT) for cirrhosis, with…

Breakthrough in Precision Cancer Therapy: Liver-Sparing in Early Studies Lehi, Utah — CancerVax, Inc., a pre-clinical biotechnology company, announced today that recent in-vitro studies demonstrate…
